Bar-Or A, Calkwood JC, Chognot C, Evershed J, et al. Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study. Neurology 2020 Jul 29. pii: WNL.0000000000010380.
PMID: 32727835